MCC

Medical Care Corporation (MCC) is a healthcare technology company specializing in the early detection and management of neurocognitive disorders, with a primary focus on Alzheimer's disease. The company's flagship product, the MCI Screen, is a highly sensitive and specific diagnostic tool used by clinicians to identify mild cognitive impairment (MCI) and early-stage dementia. MCC's technology utilizes a vast longitudinal database of cognitive performance to provide objective, evidence-based assessments that aid in clinical decision-making. Beyond clinical practice, the company provides specialized services for pharmaceutical clinical trials, assisting in patient stratification and monitoring for neurodegenerative disease research. MCC's mission is to improve patient outcomes through earlier intervention and more accurate monitoring of cognitive health.